Treosulfan Active Not Recruiting Phase 2 Trials for Leukemia Acute Myeloid Leukemia (AML) / Acute Lymphoblastic Leukaemias (ALL) / Myelodysplastic Syndromes (MDS) / Juvenile Myelomonocytic Leukaemias (JMML) Treatment

IndicationsStatusPurposePhase
Active Not RecruitingTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT02333058Treosulfan-based Conditioning in Paediatric Patients With Haematological Malignancies